Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

How Many Cores Does Systematic Prostate Biopsy Need?: A Large-Sample Retrospective Analysis.

Hu Z, Wang J, Sun D, Cui L, Ran W.

J Ultrasound Med. 2018 Oct 31. doi: 10.1002/jum.14834. [Epub ahead of print]

PMID:
30380169
2.

A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy.

Baco E, Rud E, Eri LM, Moen G, Vlatkovic L, Svindland A, Eggesbø HB, Ukimura O.

Eur Urol. 2016 Jan;69(1):149-56. doi: 10.1016/j.eururo.2015.03.041. Epub 2015 Apr 7.

3.

Diagnostic Pathway with Multiparametric Magnetic Resonance Imaging Versus Standard Pathway: Results from a Randomized Prospective Study in Biopsy-naïve Patients with Suspected Prostate Cancer.

Porpiglia F, Manfredi M, Mele F, Cossu M, Bollito E, Veltri A, Cirillo S, Regge D, Faletti R, Passera R, Fiori C, De Luca S.

Eur Urol. 2017 Aug;72(2):282-288. doi: 10.1016/j.eururo.2016.08.041. Epub 2016 Aug 27.

PMID:
27574821
4.

Prediction of Significant Prostate Cancer at Prostate Biopsy and Per Core Detection Rate of Targeted and Systematic Biopsies Using Real-Time Shear Wave Elastography.

Boehm K, Budäus L, Tennstedt P, Beyer B, Schiffmann J, Larcher A, Simonis K, Graefen M, Beyersdorff D, Salomon G.

Urol Int. 2015;95(2):189-96. doi: 10.1159/000431233. Epub 2015 Jun 3.

PMID:
26043774
5.

Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen.

Quentin M, Blondin D, Arsov C, Schimmöller L, Hiester A, Godehardt E, Albers P, Antoch G, Rabenalt R.

J Urol. 2014 Nov;192(5):1374-9. doi: 10.1016/j.juro.2014.05.090. Epub 2014 May 24.

PMID:
24866597
6.

Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies.

Arsov C, Rabenalt R, Blondin D, Quentin M, Hiester A, Godehardt E, Gabbert HE, Becker N, Antoch G, Albers P, Schimmöller L.

Eur Urol. 2015 Oct;68(4):713-20. doi: 10.1016/j.eururo.2015.06.008. Epub 2015 Jun 23.

PMID:
26116294
7.

The eternal enigma in prostatic biopsy access route.

Fabiani A, Principi E, Filosa A, Servi L.

Arch Ital Urol Androl. 2017 Oct 3;89(3):245-246. doi: 10.4081/aiua.2017.3.245.

8.

Results of Targeted Biopsy in Men with Magnetic Resonance Imaging Lesions Classified Equivocal, Likely or Highly Likely to Be Clinically Significant Prostate Cancer.

Venderink W, van Luijtelaar A, Bomers JG, van der Leest M, Hulsbergen-van de Kaa C, Barentsz JO, Sedelaar JP, Fütterer JJ.

Eur Urol. 2017 Feb 28. pii: S0302-2838(17)30110-0. doi: 10.1016/j.eururo.2017.02.021. [Epub ahead of print]

PMID:
28258784
9.

Transrectal ultrasound-guided biopsy for prostate cancer detection: Systematic and/or magnetic-resonance imaging-targeted.

Bladou F, Fogaing C, Levental M, Aronson S, Alameldin M, Anidjar M.

Can Urol Assoc J. 2017 Sep;11(9):E330-E337. doi: 10.5489/cuaj.4308.

10.

MRI Fusion-Targeted Transrectal Prostate Biopsy and the Role of Prostate-Specific Antigen Density and Prostate Health Index for the Detection of Clinically Significant Prostate Cancer in Southeast Asian Men.

Tan TW, Png KS, Lee CH, Yuwono A, Yeow Y, Chong KT, Lee YM, Tan CH, Tan YK.

J Endourol. 2017 Nov;31(11):1111-1116. doi: 10.1089/end.2017.0485. Epub 2017 Sep 15.

PMID:
28797178
11.
12.

Influence of transrectal ultrasound probe on prostate cancer detection in transrectal ultrasound-guided sextant biopsy of prostate.

Paul R, Korzinek C, Necknig U, Niesel T, Alschibaja M, Leyh H, Hartung R.

Urology. 2004 Sep;64(3):532-6.

PMID:
15351585
13.
14.

Multiparametric MRI in men with clinical suspicion of prostate cancer undergoing repeat biopsy: a prospective comparison with clinical findings and histopathology.

Boesen L, Nørgaard N, Løgager V, Balslev I, Thomsen HS.

Acta Radiol. 2018 Mar;59(3):371-380. doi: 10.1177/0284185117718400. Epub 2017 Jul 5.

PMID:
28679325
15.
16.

Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy.

Rastinehad AR, Turkbey B, Salami SS, Yaskiv O, George AK, Fakhoury M, Beecher K, Vira MA, Kavoussi LR, Siegel DN, Villani R, Ben-Levi E.

J Urol. 2014 Jun;191(6):1749-54. doi: 10.1016/j.juro.2013.12.007. Epub 2013 Dec 12.

PMID:
24333515
17.

Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers.

Hoeks CM, Schouten MG, Bomers JG, Hoogendoorn SP, Hulsbergen-van de Kaa CA, Hambrock T, Vergunst H, Sedelaar JP, Fütterer JJ, Barentsz JO.

Eur Urol. 2012 Nov;62(5):902-9. doi: 10.1016/j.eururo.2012.01.047. Epub 2012 Feb 1.

PMID:
22325447
18.

Indications for extended 14-core transrectal ultrasound-guided prostate biopsy.

Uno H, Nakano M, Ehara H, Deguchi T.

Urology. 2008 Jan;71(1):23-7. doi: 10.1016/j.urology.2007.09.020.

PMID:
18242358
19.

Detection of Significant Prostate Cancer According to Anatomical Areas of Sampling Cores Obtained with Transrectal Systematic 12-Core Biopsy.

Tei H, Miyake H, Harada K, Fujisawa M.

Curr Urol. 2015 Jul;8(2):91-5. doi: 10.1159/000365696. Epub 2015 Jul 10.

20.

Supplemental Content

Support Center